Page last updated: 2024-10-23

bromperidol and Koch's Disease

bromperidol has been researched along with Koch's Disease in 1 studies

bromperidol: bromine-substituted for chlorine in haloperidol; RN given refers to unlabeled parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
"Spectinomycin was used to test the concept that clinically available antibiotics with limited efficacy against Mycobacterium tuberculosis might be used for TB treatment when coadministered with a synergistic partner compound used as a sensitizer."1.37Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. ( Anderson, H; Av-Gay, Y; Chao, JD; Ng, C; Pfeifer, T; Ramón-García, S; Roberge, M; Thompson, CJ; Zheng, X, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramón-García, S1
Ng, C1
Anderson, H1
Chao, JD1
Zheng, X1
Pfeifer, T1
Av-Gay, Y1
Roberge, M1
Thompson, CJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy: Comparison of 8 Weeks Standard Therapy (Rifampicin Plus Clarithromycin) vs. 4 Weeks Standard Plus Amoxicillin/Clavulanate Therapy [RC8 vs. RCA4][NCT05169554]Phase 2140 participants (Anticipated)Interventional2021-12-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for bromperidol and Koch's Disease

ArticleYear
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Haloperidol; High-Throughput Scree

2011